
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
HACE1 CRISPR/Cas9 KO Plasmid (m) | sc-431639 | 20 µg | $397.00 | |||
HACE1 HDR Plasmid (m) | sc-431639-HDR | 20 µg | $445.00 |
Mouse Hace1 encodes HACE1, a HECT-type E3 ubiquitin ligase that regulates protein turnover and signaling through ubiquitin-mediated proteasomal degradation. HACE1 has been linked to control of small GTPase pathways, including ubiquitination of RAC1, thereby influencing cytoskeletal dynamics, oxidative stress responses, and cell migration. By shaping proteostasis and stress-adaptive signaling, HACE1 contributes to mechanisms relevant to genome stability and cellular transformation. Dysregulation of HACE1 expression or activity has been associated with cancer-related phenotypes and altered responses to cellular stress, making it a useful node for pathway dissection in mouse models.
HACE1 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Hace1 gene in mouse cell lines. Each plasmid in the pool co-expresses a unique sgRNA, targeting a distinct site within the Hace1 locus, alongside the Streptococcus pyogenes Cas9 nuclease, and encodes GFP to enable fluorescent identification and enrichment of successfully transfected cells. This multi-guide strategy increases the likelihood of inducing frameshifts or deletions that produce a functional knockout, offering a more robust alternative to single-guide approaches. DSBs induced at multiple sites are resolved through non-homologous end joining (NHEJ) or, when used with the included HDR donor template, homology-directed repair (HDR) at a defined target site within the locus.
When used in conjunction with the RFP-expressing HDR donor, GFP and RFP fluorescence can be used together to distinguish transfected from edited cell populations, streamlining flow cytometry-based sorting and clone selection workflows.
For applications requiring confirmed, selectable knockout clones, HACE1 HDR Plasmid (m) includes an HDR donor construct containing a puromycin resistance cassette (PuroR) and a red fluorescent protein (RFP) reporter, flanked by homology arms specific to a defined Hace1 target site.
When co-transfected with HACE1 CRISPR/Cas9 KO Plasmid (m):
The HDR donor construct features loxP sites flanking the PuroR-RFP selection cassette to allow clean marker removal following clone confirmation. Transient expression of Cre recombinase via the included Cre Vector: sc-418923 excises the cassette, leaving a minimal residual loxP site within the Hace1 locus and eliminating potential confounding effects on downstream assays.
This two-step approach:
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.